Modulating NK cell metabolism for cancer immunotherapy

Area of Science:

• Immunology
• Cancer Biology
• Metabolism

Background:

• Natural killer (NK) cells are crucial lymphocytes with significant anti-tumor capabilities, leading to the development of NK cell-based cancer immunotherapies.
• Current immunotherapies necessitate novel strategies to enhance NK cell efficacy, with immunometabolism emerging as a promising therapeutic target.
• NK cell effector functions are closely tied to their metabolic state, suggesting that metabolic modulation could unlock their full therapeutic potential.

Purpose of the Study:

• To review the regulation of NK cell metabolism during key biological processes like maturation, viral infection, and cytokine stimulation.
• To examine the impact of current therapeutic strategies on NK cell metabolism, expansion, and effector functions.
• To explore strategies for overcoming metabolic deficits in tumor-infiltrating NK cells and to identify metabolic therapies that synergize with NK cell-based immunotherapies.

Main Methods:

• Literature review of studies on NK cell metabolism, cancer immunotherapy, and metabolic targeting.
• Synthesis of information on NK cell metabolic regulation in various physiological and pathological contexts.
• Analysis of current and potential therapeutic interventions affecting NK cell function and metabolism.

Main Results:

• NK cell metabolism is dynamically regulated by maturation, infections, and cytokine signaling.
• Therapeutic interventions can influence NK cell metabolism, impacting their expansion and effector functions.
• Tumor microenvironments often impose metabolic constraints on NK cells, impairing their anti-tumor activity.
• Metabolic strategies targeting cancer and NK cells hold potential for synergistic therapeutic effects.

Conclusions:

• Modulating NK cell metabolism is a viable strategy to enhance their anti-tumor functions in cancer immunotherapy.
• Addressing metabolic impairments in tumor-infiltrating NK cells is critical for restoring their efficacy.
• Combined approaches targeting both NK cell metabolism and cancer metabolism may significantly improve immunotherapy outcomes.